CBLI Cleveland BioLabs Inc.

3.21
+1.89  (+143%)
Previous Close 1.32
Open 3.11
Price To Book -10.7
Market Cap 36,267,347
Shares 11,298,239
Volume 10,088,642
Short Ratio
Av. Daily Volume 82,923
Stock charts supplied by TradingView

NewsSee all news

  1. Cleveland BioLabs Reports Third Quarter 2019 Financial Results and Development Progress

    BUFFALO, NY / ACCESSWIRE / November 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the third quarter ended September 30, 2019.Cleveland BioLabs reported a

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 1 extension trial ongoing.
ENTOLIMOD
Solid tumors

Latest News

  1. Cleveland BioLabs Reports Third Quarter 2019 Financial Results and Development Progress

    BUFFALO, NY / ACCESSWIRE / November 14, 2019 / Cleveland BioLabs, Inc. (NASDAQ:CBLI) today reported financial results and development progress for the third quarter ended September 30, 2019.Cleveland BioLabs reported a